BG63938B1 - Бензамидинови производни и използването им като лекарствени средства с ltb4-антагонистично действие - Google Patents

Бензамидинови производни и използването им като лекарствени средства с ltb4-антагонистично действие Download PDF

Info

Publication number
BG63938B1
BG63938B1 BG103219A BG10321999A BG63938B1 BG 63938 B1 BG63938 B1 BG 63938B1 BG 103219 A BG103219 A BG 103219A BG 10321999 A BG10321999 A BG 10321999A BG 63938 B1 BG63938 B1 BG 63938B1
Authority
BG
Bulgaria
Prior art keywords
alkyl
unbranched
branched
hydrogen
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
BG103219A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG103219A (en
Inventor
Kurt Schromm
Ralf Anderskewitz
Ernst-Otto Renth
Franz Birke
Hans Jennewein
Christopher Meade
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH Co KG
Original Assignee
Boehringer Ingelheim Pharma GmbH Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma GmbH Co KG filed Critical Boehringer Ingelheim Pharma GmbH Co KG
Publication of BG103219A publication Critical patent/BG103219A/xx
Publication of BG63938B1 publication Critical patent/BG63938B1/bg
Anticipated expiration legal-status Critical
Active legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/18Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/62Compounds containing any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylcarbamates
    • C07C271/64Y being a hydrogen or a carbon atom, e.g. benzoylcarbamates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Hydrogenated Pyridines (AREA)
BG103219A 1996-09-10 1999-03-01 Бензамидинови производни и използването им като лекарствени средства с ltb4-антагонистично действие Active BG63938B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19636689A DE19636689A1 (de) 1996-09-10 1996-09-10 Neue Benzamidinderivate
PCT/EP1997/004921 WO1998011062A1 (de) 1996-09-10 1997-09-09 Benzamidinderivate und ihre verwendung als arzneimittel mit ltb4-antagonistischer wirkung

Publications (2)

Publication Number Publication Date
BG103219A BG103219A (en) 1999-10-29
BG63938B1 true BG63938B1 (bg) 2003-07-31

Family

ID=7805125

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103219A Active BG63938B1 (bg) 1996-09-10 1999-03-01 Бензамидинови производни и използването им като лекарствени средства с ltb4-антагонистично действие

Country Status (31)

Country Link
US (2) US6197824B1 (ja)
EP (2) EP0929516B1 (ja)
JP (2) JP4150427B2 (ja)
KR (1) KR20000036005A (ja)
CN (1) CN1104412C (ja)
AR (1) AR009741A1 (ja)
AT (2) ATE266630T1 (ja)
AU (1) AU727900B2 (ja)
BG (1) BG63938B1 (ja)
BR (1) BR9712816A (ja)
CA (1) CA2262566C (ja)
CO (1) CO4900032A1 (ja)
CZ (1) CZ297252B6 (ja)
DE (3) DE19636689A1 (ja)
DK (1) DK0929516T3 (ja)
EA (1) EA003245B1 (ja)
EE (1) EE04431B1 (ja)
ES (1) ES2184131T3 (ja)
HK (1) HK1020564A1 (ja)
HU (1) HUP9904367A3 (ja)
IL (1) IL128144A (ja)
NO (1) NO312239B1 (ja)
NZ (1) NZ334895A (ja)
PL (1) PL188012B1 (ja)
PT (1) PT929516E (ja)
SK (1) SK282432B6 (ja)
TR (1) TR199900501T2 (ja)
TW (1) TW378200B (ja)
UA (1) UA60315C2 (ja)
WO (1) WO1998011062A1 (ja)
ZA (1) ZA978045B (ja)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID29066A (id) 1998-12-14 2001-07-26 Hoffmann La Roche Turunan fenilglisina
US6291531B1 (en) * 1999-10-07 2001-09-18 Boehringer Ingelheim Pharma Kg LTB4 antagonist, processes for the preparation thereof and its use as a pharmaceutical composition
DE19948428A1 (de) * 1999-10-07 2001-04-12 Boehringer Ingelheim Pharma Neuer LTB¶4¶-Antagonist, Verfahren zu dessen Herstellung und dessen Verwendung als Arzneimittel
DE10052658A1 (de) * 2000-10-24 2002-05-02 Boehringer Ingelheim Pharma Neue Pyranosidderivate
DE10052333A1 (de) * 2000-10-24 2002-05-02 Boehringer Ingelheim Pharma Neue Sulfooxybenzamide
US6489359B2 (en) 2000-10-24 2002-12-03 Boehringer Ingelheim Pharma Kg Sulphoxybenzamides
US6528491B2 (en) 2000-10-24 2003-03-04 Boehringer Ingelheim Pharma Kg Pyranoside derivatives
US7776315B2 (en) * 2000-10-31 2010-08-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and additional active ingredients
US6608054B2 (en) * 2001-03-20 2003-08-19 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics and endothelin antagonists
AU4239302A (en) * 2001-06-28 2003-01-02 Pfizer Products Inc. Benzoic acid substituted benzopyrans for the treatment of atherosclerosis
US20030119901A1 (en) * 2001-07-14 2003-06-26 Boehringer Ingelheim Pharma Kg Pharmaceutical formulation containing an LTB4 antagonist
NZ530973A (en) * 2001-07-14 2006-07-28 Boehringer Ingelheim Pharma Pharmaceutical formulation containing an LTB4 antagonist
CN1658852A (zh) * 2001-08-31 2005-08-24 神经化学(国际)有限公司 用于治疗淀粉样变性的脒衍生物
DE10213350A1 (de) * 2002-03-26 2003-10-16 Boehringer Ingelheim Pharma Verwendung von LTB¶4¶Antagonisten in der Tiermedizin
US6921752B2 (en) * 2002-03-26 2005-07-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of LTB4 antagonists in veterinary medicine
RS20050390A (en) * 2002-11-26 2008-04-04 Boehringer Ingelheim Pharma Gmbh. & Co.Kg., Pharmaceutical composition comprising a ltb4 antagonist and a cox-2 inhibitor or a combined cox 1/2 inhibitor
US7262223B2 (en) * 2004-01-23 2007-08-28 Neurochem (International) Limited Amidine derivatives for treating amyloidosis
CN1997367B (zh) * 2004-07-05 2010-11-24 同和药品株式会社 预防和治疗过敏性炎症的组合物
KR20060017929A (ko) * 2004-08-04 2006-02-28 동화약품공업주식회사 티아졸 유도체가 치환된 신규한 벤즈아미딘 유도체, 그의제조방법 및 이를 유효성분으로 하는 약학 조성물
US8679288B2 (en) * 2008-06-09 2014-03-25 Lam Research Corporation Showerhead electrode assemblies for plasma processing apparatuses
CN106831611B (zh) * 2017-01-23 2019-06-21 北京化工大学 一种偕胺肟类化合物及其在制备抑制癌细胞增殖药的应用
EP3623368A4 (en) 2017-05-12 2021-04-07 Riken CLASS A GPCR BINDING COMPOUND MODIFIER
WO2020061688A1 (en) * 2018-09-24 2020-04-02 The University Of British Columbia Modulation of granzyme k activity in the treatment of skin conditions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4102024A1 (de) * 1991-01-24 1992-07-30 Thomae Gmbh Dr K Biphenylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
US5246965A (en) 1991-06-11 1993-09-21 Ciba-Geigy Arylethers, their manufacture and methods of treatment
EP0518818A3 (en) * 1991-06-11 1993-04-28 Ciba-Geigy Ag Arylethers, their manufacture and use as medicament
PT902013E (pt) 1992-02-05 2002-06-28 Boehringer Ingelheim Pharma Novos derivados amidina sua preparacao e utilizacao como medicamento com actividade antagonista de ltb4
DE4219158A1 (de) * 1992-06-11 1993-12-16 Thomae Gmbh Dr K Biphenylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE4424713A1 (de) * 1994-07-13 1996-01-18 Boehringer Ingelheim Kg Substituierte Benzamidine, ihre Herstellung und Verwendung als Arnzneistoffe
DE4424714A1 (de) * 1994-07-13 1996-01-18 Boehringer Ingelheim Kg Neue chemische Verbindung, ihre Herstellung und ihre Verwendung als Arnzneistoff
DE19546452A1 (de) * 1995-12-13 1997-06-19 Boehringer Ingelheim Kg Neue Phenylamidinderivate, Verfahren zu ihrer Herstelung und ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
EP0929516B1 (de) 2002-09-18
CN1230174A (zh) 1999-09-29
BG103219A (en) 1999-10-29
NO991131D0 (no) 1999-03-09
DE59711625D1 (de) 2004-06-17
HUP9904367A3 (en) 2001-11-28
ATE224363T1 (de) 2002-10-15
CZ297252B6 (cs) 2006-10-11
AU727900B2 (en) 2001-01-04
ZA978045B (en) 1998-03-10
PT929516E (pt) 2003-01-31
DK0929516T3 (da) 2003-01-13
JP4150427B2 (ja) 2008-09-17
AU4383897A (en) 1998-04-02
ATE266630T1 (de) 2004-05-15
HUP9904367A2 (hu) 2000-05-28
BR9712816A (pt) 1999-11-23
SK29699A3 (en) 2000-03-13
EE04431B1 (et) 2005-02-15
EP1203764A1 (de) 2002-05-08
IL128144A (en) 2004-07-25
NO991131L (no) 1999-03-09
PL188012B1 (pl) 2004-11-30
DE59708278D1 (de) 2002-10-24
NZ334895A (en) 2000-09-29
JP2008266333A (ja) 2008-11-06
US6265612B1 (en) 2001-07-24
CO4900032A1 (es) 2000-03-27
NO312239B1 (no) 2002-04-15
KR20000036005A (ko) 2000-06-26
HK1020564A1 (en) 2000-05-12
TW378200B (en) 2000-01-01
CN1104412C (zh) 2003-04-02
EA199900279A1 (ru) 1999-08-26
PL332136A1 (en) 1999-08-30
EA003245B1 (ru) 2003-02-27
WO1998011062A1 (de) 1998-03-19
TR199900501T2 (xx) 1999-07-21
SK282432B6 (sk) 2002-02-05
ES2184131T3 (es) 2003-04-01
JP4288299B2 (ja) 2009-07-01
EP1203764B1 (de) 2004-05-12
DE19636689A1 (de) 1998-03-12
CZ82299A3 (cs) 1999-09-15
US6197824B1 (en) 2001-03-06
IL128144A0 (en) 1999-11-30
EE9900086A (et) 1999-10-15
CA2262566C (en) 2006-07-11
JP2001504087A (ja) 2001-03-27
CA2262566A1 (en) 1998-03-19
EP0929516A1 (de) 1999-07-21
UA60315C2 (uk) 2003-10-15
AR009741A1 (es) 2000-05-03

Similar Documents

Publication Publication Date Title
BG63938B1 (bg) Бензамидинови производни и използването им като лекарствени средства с ltb4-антагонистично действие
FI84178C (fi) Foerfarande foer framstaellning av antianxietiska och antihypertensiva glutarimidderivat.
RU2293727C2 (ru) Амиды антраниловой кислоты с гетероарилсульфонильной боковой цепью и содержащие их фармацевтические композиции
EP0516941B1 (en) Pyrazolopyridine compounds and processes for preparation thereof
DK164450B (da) Alkylsulfonamidophenylalkylaminer eller syreadditionssalte deraf, farmaceutiske formuleringer indeholdende saadanne forbindelser og fremgangsmaade til fremstilling af forbindelserne
WO2008054454A2 (en) Nitrogen-containing heterocycle derivatives, pharmaceutical compositions, and methods of use thereof as antiviral agents
IT9021075A1 (it) Derivati acidi benzoici sostituiti ad attivita' cardiovascolare
US4381398A (en) Amino-alcohol derivatives
JP2001525399A (ja) 選択的β3アドレナリン作動性作動薬
AU715493B2 (en) Selective beta 3 adrenergic agonists
CA1167465A (en) Substituted 3-phenoxy-1-alkoxycarbonyl-alkylamino- propanol-2-s having beta receptor blocking properties
US5652232A (en) Benzolactam derivatives
HU211517A9 (en) 2-amino-1,2,3,4-tetrahydronaphthalene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them
CA3136725A1 (en) Inhibitors of cd40-cd154 binding
WO1998043943A1 (fr) Derives de 2-phenoxyaniline
US5294638A (en) Phenyalkylaminoalkyl compounds and pharmaceutical compositions containing them
AU2004276128A1 (en) Amide-type carboxamide derivatives
EP0279633B1 (en) Anticonvulsant agents
CN110041272B (zh) 2-(2-氯苯基)喹唑啉-4(3h)-酮类衍生物及其制备方法和用途
EP0934257B1 (en) Substituted n-arylmethylamino derivatives of cyclobutene-3,4-diones
EP0197386B1 (en) 2-(substituted sulfamyl) derivatives of 6-nitrobenzoic acid, process for their preparation and pharmaceutical compositions containing them
JPS62132844A (ja) 塩基性基により置換されたフエニルアセトアルデヒド、その製法及びそれを含有する医薬
KR20010102401A (ko) 폴리사이클릭 2-아미노-디하이드로티아졸 시스템, 이의제조방법 및 약제로서의 이의 용도
WO1993025520A1 (en) 5-amino-2-phenoxysulfonanilide compound
MXPA99001797A (en) Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect